Dr. Emily Watson
Associate Professor of Hematology
Memorial Sloan Kettering Cancer Center
New York, New York, United States
AML Immunotherapy Clinical Trials
Biography
Dr. Watson is a leading expert in immunotherapy for acute myeloid leukemia,
with particular focus on next-generation CAR-T cell therapies and combination
immunotherapy approaches. Her research has contributed to significant advances
in AML treatment, particularly for patients who haven't responded to standard
therapies.
She leads several clinical trials exploring innovative immunotherapy
combinations and has published extensively on AML biology and treatment.
Dr. Watson is committed to developing more effective and accessible
immunotherapy options for AML patients.
Education
- MD • Columbia University College of Physicians and Surgeons (2011)
- PhD in Immunology • Rockefeller University (2011)
Awards & Honors
- • ASCO Career Development Award
- • LLS Scholar Award
- • Young Investigator Award - American Society of Hematology